BenevolentAI Archives

Home BenevolentAI

Latest Posts

BIO-Europe Spring, Element Materials Technology, Ergomed, Rentschler Biosciences

News and Trends 8 Mar 2023

How to promote diversity in STEM

Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass Therapeutics is a female-led business with diversity at its core.…

March 8, 2023 - 6 minutesmins - By Jim Cornall

News and Trends 7 Oct 2021

Exscientia IPO Attracts Tech Investor Bets to AI Drug Discovery

Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts to use artificial intelligence to fuel drug discovery, with global tech investors often taking the…

October 7, 2021 - 5 minutesmins - By Mark Zipkin

News and Trends 9 Nov 2016

British Artificial Intelligence will soon run Clinical Trials

Artificial Intelligence can make clinical trials cheaper and faster, and this British start-up is about to start testing its technology to optimize drug development. BenevolentAI is a London start-up that…

November 9, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

In Depth 3 Oct 2017

How Close Are We to Curing ALS? A Review of Biotech’s Efforts

May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug in 20 years, when Edaravone/Radicava, developed by Japanese company MT Pharma, received orphan drug registration.…

October 3, 2017 - 8 minutesmins - By Ute Boronowsky

AI artificial intelligence machine learning biotech

In Depth 5 Mar 2018

The Robots are Coming: Is AI the Future of Biotech?

AI, or artificial intelligence, has taken root in biotech. In this article, we explore its newfound niches in the industry. Artificial intelligence (AI) and machine learning (ML) have become ubiquitous in…

March 5, 2018 - 7 minutesmins - By External Contributor

BenevolentAI Artificial Intelligence Fundraising

Interview 20 Mar 2017

Machines are Helping Healthcare: An Interview with their Biotech Leader

BenevolentAI is leading the charge in artificial intelligence. We talked to Jackie Hunter, who is the CEO of the company’s bioscience arm, BenevolentBio. [caption id="attachment_43427" align="alignright" width="197"] Jackie Hunter[/caption] Jackie…

March 20, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 19 Apr 2018

Major $115M Fundraising Fuels AI Drug Development

BenevolentAI has raised a massive second round of fundraising to expand the drug developing capabilities of its artificial intelligence technology. The technology could significantly increase the speed and efficiency of…

April 19, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 28 Mar 2018

AI Is Being Put to Work to Treat Parkinson’s Disease in the UK

The artificial intelligence company BenevolentAI is collaborating with two UK charities to use AI to identify ideal drug candidates for treating Parkinson's disease. BenevolentAI, Europe's largest private AI company, is…

March 28, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 27 Sep 2017

German Researchers’ Algorithm Can Predict New Targets for Existing Drugs

An algorithm based on the brain's self-organizing capacity has been developed in Germany that could combat the rising costs of drug development. A team at TU Dresden has pioneered an algorithm…

September 27, 2017 - 3 minutesmins - By Alex Dale

artificial intelligence alzheimers neuroscience

In Depth 21 Sep 2017

How Will Artificial Intelligence Impact Alzheimer’s Research?

Last week, worldwide leaders gathered at the Artificial Intelligence in Bioscience Symposium in London to examine the growing role AI plays in healthcare, highlighting neuroscience and particularly Alzheimer's as one…

September 21, 2017 - 5 minutesmins - By External Contributor

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

Download Inpart’s latest report

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering